Grossmann, Mathis <br/><br/>
Androgen deprivation therapy in men with prostate cancer: how should the side effects be monitored and treated?  [electronic resource] 

 -  Clinical endocrinology  Mar 2011 
 - 289-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2265 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2265.2010.03939.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--adverse effects<br/>Antineoplastic Agents, Hormonal--adverse effects<br/>Cardiovascular Diseases--diagnosis<br/>Drug-Related Side Effects and Adverse Reactions--diagnosis<br/>Fractures, Bone--prevention & control<br/>Humans<br/>Male<br/>Prostatic Neoplasms--drug therapy<br/>Quality of Life<br/>Risk Assessment<br/>Risk Factors<br/>Treatment Outcome